Blirt SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blirt SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11194
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blirt SA (Blirt) is a biotechnology company that produces specialty enzymes utilized in nucleic acid for purification and sequencing. The company offers recombinant protein and molecular biology products. It provides protein products such as proteinases, RNase inhibitors, reverse transciptases, polymerases, ligases, and other proteins. Blirt’s reagents include DNA and RNA isolation kits, real-time PCR mixes, PCR reagents, reverse transcription, enzymes and proteins, electrophoresis, and educational kits. The compay’s services include molecular biology and GLP analytical services, bio-analytical, genomic, contract manufacturing services, and biological research reagent manufacturing. It caters to pharmaceutical and biotech companies. Blirt is headquartered in Gdansk, Poland.

Blirt SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blirt SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 11
Licensing Agreements 12
Blirt Plans To Out-License Antifungal Assets 12
Equity Offering 13
Blirt to Raise USD0.3 Million in Private Placement of Series N Shares 13
Blirt Raises USD0.1 Million in Public Offering of Shares 14
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 15
Blirt to Raise Funds through Private Placement of Series A Warrants 16
Blirt SA – Key Competitors 17
Blirt SA – Key Employees 18
Blirt SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Blirt SA, Pharmaceuticals & Healthcare, Key Facts 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 11
Blirt Plans To Out-License Antifungal Assets 12
Blirt to Raise USD0.3 Million in Private Placement of Series N Shares 13
Blirt Raises USD0.1 Million in Public Offering of Shares 14
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 15
Blirt to Raise Funds through Private Placement of Series A Warrants 16
Blirt SA, Key Competitors 17
Blirt SA, Key Employees 18
Blirt SA, Other Locations 19
Blirt SA, Subsidiaries 19

List of Figures
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Blirt SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AWE Ltd (AWE)-石油・ガス分野:企業M&A・提携分析
    Summary AWE Ltd (AWE) is an independent upstream oil and gas company. It focuses on the exploration, production and sale of oil, gas and condensate. The company has a diverse portfolio of upstream assets in Australia, New Zealand, and Indonesia. Its producing assets include BassGas project in Tasman …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Life Insurance Corporation of India:企業の戦略的SWOT分析
    Life Insurance Corporation of India - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Hunter Oil Corp (HOC):石油・ガス:M&Aディール及び事業提携情報
    Summary Hunter Oil Corp (HOC), formerly Enhanced Oil Resources Inc is an oil and gas company that offers energy production programs. The company offers production and rehabilitation of its legacy oil fields through full cycle development. It also provides full cycle development services such as rese …
  • Dai Nippon Printing Co., Ltd.:企業の戦略・SWOT・財務分析
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Conn’S, Inc.
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • New Gold Inc:企業の戦略・SWOT・財務分析
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • B2W – Companhia Global Do Varejo:企業の戦略・SWOT・財務分析
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …
  • Gulf Keystone Petroleum Ltd (GKP):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • easyJet Plc:企業の戦略・SWOT・財務情報
    easyJet Plc - Strategy, SWOT and Corporate Finance Report Summary easyJet Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hoteli-Metropol AD Ohrid:企業の戦略・SWOT・財務情報
    Hoteli-Metropol AD Ohrid - Strategy, SWOT and Corporate Finance Report Summary Hoteli-Metropol AD Ohrid - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Urigen Pharmaceuticals Inc:企業の戦略的SWOT分析
    Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ceres Power Holdings Plc (CWR):電力:M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • OMV New Zealand Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary OMV New Zealand Ltd (OMV NZ) a subsidiary of OMV AG, is an oil and natural gas exploration and production company. It offers upstream production services with offshore oil and gas fields in Maari, Pohokura, and Maui across Taranaki coast, Tunisia and in the Black Sea. The company operates ex …
  • Altor BioScience Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Altor BioScience Corp (Altor BioScience) is a biopharmaceutical company that develops immunotherapies for the treatment of cancer and viral infections. The company’s pipeline products include ALT-801, ALT-836, and ALT-803. Its technologies are soluble t-cell antigen receptor, inhibitor of MH …
  • Showa Shell Sekiyu KK (5002):企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆